The Oncological Breakthrough of Obesity Medications: Mechanisms of Cancer Prevention, Metastasis Inhibition, and Structural Shifts in the Global Pharmaceutical Market 1. Overview: From Metabolic Therapies to Oncological Platform Drugs Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), once confined to the therapeutic domains of type 2 diabetes mellitus (T2DM) and weight loss, have recently been spearheading a…